Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders

Progress in Neurobiology

Volumn 134, Issue , 2015, Pages 36-54

  Heyes, Samuel ^a   Pratt, Wendy S ^a   Rees, Elliott ^b   Dahimene, Shehrazade ^a   Ferron, Laurent ^a   Owen, Michael J ^b   Dolphin, Annette C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Calcium channel; Mutation; Neuropsychiatric disorder; Polygenic disorder; Single nucleotide polymorphism

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL R TYPE; CALCIUM CHANNEL T TYPE; DIHYDROPYRIDINE; FRAGILE X MENTAL RETARDATION PROTEIN; MIBEFRADIL; OMEGA CONOTOXIN GVIA; SNX 482; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL 1.1; VOLTAGE GATED CALCIUM CHANNEL 1.2; VOLTAGE GATED CALCIUM CHANNEL 1.3; VOLTAGE GATED CALCIUM CHANNEL 1.4; VOLTAGE GATED CALCIUM CHANNEL 2.1; VOLTAGE GATED CALCIUM CHANNEL 2.2; VOLTAGE GATED CALCIUM CHANNEL 2.3; VOLTAGE GATED CALCIUM CHANNEL 3.1; VOLTAGE GATED CALCIUM CHANNEL 3.2; VOLTAGE GATED CALCIUM CHANNEL 3.3; CALCIUM CHANNEL;

AMINO ACID SUBSTITUTION; AUTISM; BIPOLAR DISORDER; BRAIN DEVELOPMENT; CAG REPEAT; CALCIUM CHANNELOPATHY; FRAGILE X SYNDROME; FRAMESHIFT MUTATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GERMLINE MUTATION; HUMAN; HYPERALDOSTERONISM; INTELLECTUAL IMPAIRMENT; MENTAL DISEASE; MONOGENIC DISORDER; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SPLICING DEFECT; STOP CODON; TIMOTHY SYNDROME; ANIMAL; GENETICS; MENTAL DISORDERS; METABOLISM; MUTATION; NERVOUS SYSTEM DISEASES;

ANIMALS; CALCIUM CHANNELS; HUMANS; MENTAL DISORDERS; MUTATION; NERVOUS SYSTEM DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84947227793     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2015.09.002     Document Type: Review

References (260)

1. Altier C., Dale C.S., Kisilevsky A.E., Chapman K., Castiglioni A.J., Matthews E.A., Evans R.M., Dickenson A.H., Lipscombe D., Vergnolle N., Zamponi G.W. Differential role of N-type calcium channel splice isoforms in pain. J. Neurosci. 2007, 27:6363-6373.
2. Antar L.N., Afroz R., Dictenberg J.B., Carroll R.C., Bassell G.J. Metabotropic glutamate receptor activation regulates fragile × mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. J. Neurosci. 2004, 24:2648-2655.
3. Antar L.N., Li C., Zhang H., Carroll R.C., Bassell G.J. Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol. Cell Neurosci. 2006, 32:37-48.
4. Azizan E.A., Poulsen H., Tuluc P., Zhou J., Clausen M.V., Lieb A., Maniero C., Garg S., Bochukova E.G., Zhao W., Shaikh L.H., Brighton C.A., Teo A.E., Davenport A.P., Dekkers T., Tops B., Kusters B., Ceral J., Yeo G.S., Neogi S.G., McFarlane I., Rosenfeld N., Marass F., Hadfield J., Margas W., Chaggar K., Solar M., Deinum J., Dolphin A.C., Farooqi I.S., Striessnig J., Nissen P., Brown M.J. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat. Genet. 2013, 45:1055-1060.
5. Bader P.L., Faizi M., Kim L.H., Owen S.F., Tadross M.R., Alfa R.W., Bett G.C., Tsien R.W., Rasmusson R.L., Shamloo M. Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc. Natl. Acad. Sci. USA 2011, 108:15432-15437.
6. Baig S.M., Koschak A., Lieb A., Gebhart M., Dafinger C., Nurnberg G., Ali A., Ahmad I., Sinnegger-Brauns M.J., Brandt N., Engel J., Mangoni M.E., Farooq M., Khan H.U., Nurnberg P., Striessnig J., Bolz H.J. Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat. Neurosci. 2011, 14:77-84.
7. Bannister R.A., Beam K.G. Ca(V)1.1: The atypical prototypical voltage-gated Ca(2)(+) channel. Biochim. Biophys. Acta 2013, 1828:1587-1597.
8. Barclay J., Balaguero N., Mione M., Ackerman S.L., Letts V.A., Brodbeck J., Canti C., Meir A., Page K.M., Kusumi K., PerezReyes E., Lander E.S., Frankel W.N., Gardiner R.M., Dolphin A.C., Rees M. Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells. J. Neurosci. 2001, 21:6095-6104.
9. Barrett C.F., Tsien R.W. The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc. Natl. Acad. Sci. USA 2008, 105:2157-2162.
10. Bassell G.J., Warren S.T. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 2008, 60:201-214.
11. Bauer C.S., Nieto-Rostro M., Rahman W., Tran-Van-Minh A., Ferron L., Douglas L., Kadurin I., Sri Ranjan Y., Fernandez-Alacid L., Millar N.S., Dickenson A.H., Lujan R., Dolphin A.C. The increased trafficking of the calcium channel subunit α2δ-1 to presynaptic terminals in neuropathic pain is inhibited by the α2δ ligand pregabalin. J. Neurosci. 2009, 29:4076-4088.
12. Bean B.P., Sturek M., Puga A., Hermsmeyer K. Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs. Circ. Res. 1986, 59:229-235.
13. 2+ channel antagonist mibefradil (Ro 40-5967). Mol. Pharmacol. 1995, 48:540-549.
14. Bhakar A.L., Dolen G., Bear M.F. The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 2012, 35:417-443.
15. Bigos K.L., Mattay V.S., Callicott J.H., Straub R.E., Vakkalanka R., Kolachana B., Hyde T.M., Lipska B.K., Kleinman J.E., Weinberger D.R. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch. Gen. Psychiatry 2010, 67:939-945.
16. Boczek N.J., Miller E.M., Ye D., Nesterenko V.V., Tester D.J., Antzelevitch C., Czosek R.J., Ackerman M.J., Ware S.M. Novel Timothy syndrome mutation leading to increase in CACNA1C window current. Heart Rhythm. 2015, 12:211-219.
17. Boland L.M., Morrill J.A., Bean B.P. Omega-Conotoxin block of N-type calcium channels in frog and rat sympathetic neurons. J. Neurosci. 1994, 14:5011-5027.
18. Bourdin B., Shakeri B., Tetreault M.P., Sauve R., Lesage S., Parent L. Functional characterization of CaValpha2delta mutations associated with sudden cardiac death. J. Biol. Chem. 2015, 290:2854-2869.
19. V2.3) calcium channels. Biophys. J. 2001, 81:79-88.
20. Bowersox S.S., Gadbois T., Singh T., Pettus M., Wang Y.X., Luther R.R. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J. Pharmacol. Exp. Ther. 1996, 279:1243-1249.
21. Boyle L., Kaufmann W.E. The behavioral phenotype of FMR1 mutations. Am. J. Med. Genet. C Semin. Med. Genet. 2010, 154C:469-476.
22. Breitenkamp A.F., Matthes J., Nass R.D., Sinzig J., Lehmkuhl G., Nurnberg P., Herzig S. Rare mutations of CACNB2 found in autism spectrum disease-affected families alter calcium channel function. PLoS ONE 2014, 9:e95579.
23. Brill J., Klocke R., Paul D., Boison D., Gouder N., Klugbauer N., Hofmann F., Becker C.M., Becker K. entla, a novel epileptic and ataxic Cacna2d2 mutant of the mouse. J. Biol. Chem. 2004, 279:7322-7330.
24. Brown M.R., Kronengold J., Gazula V.R., Chen Y., Strumbos J.G., Sigworth F.J., Navaratnam D., Kaczmarek L.K. Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack. Nat. Neurosci. 2010, 13:819-821.
25. Brown T.M., Brotchie J.M., Fitzjohn S.M. Cannabinoids decrease corticostriatal synaptic transmission via an effect on glutamate uptake. J. Neurosci. 2003, 23:11073-11077.
26. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D., Darnell R.B., Warren S.T. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 2001, 107:477-487.
27. Burashnikov E., Pfeiffer R., Barajas-Martinez H., Delpon E., Hu D., Desai M., Borggrefe M., Haissaguerre M., Kanter R., Pollevick G.D., Guerchicoff A., Laino R., Marieb M., Nademanee K., Nam G.B., Robles R., Schimpf R., Stapleton D.D., Viskin S., Winters S., Wolpert C., Zimmern S., Veltmann C., Antzelevitch C. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm. 2010, 7:1872-1882.
28. 2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 1997, 88:385-392.
29. 2+ channel isoforms in the extinction of conditioned fear. Learn. Mem. 2008, 15:378-386.
30. Canti C., Davies A., Berrow N.S., Butcher A.J., Page K.M., Dolphin A.C. Evidence for two concentration-dependent processes for β subunit effects on α1B calcium channels. Biophys. J. 2001, 81:1439-1451.
31. 2+ channels to channel-interacting slots in controlling neurotransmission at cultured hippocampal synapses. J. Neurosci. 2010, 30:4536-4546.
32. Carbone E., Calorio C., Vandael D.H. T-type channel-mediated neurotransmitter release. Pflugers Arch. 2014, 466:677-687.
33. Carbone E., Lux H.D. A low voltage-activated fully inactivating Ca channel in vertebrate sensory neurones. Nature 1984, 310:501-502.
34. Catterall W.A., Leal K., Nanou E. Calcium channels and short-term synaptic plasticity. J. Biol. Chem. 2013, 288:10742-10749.
35. Catterall W.A., Striessnig J., Snutch T.P., Perez-Reyes E. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacol. Rev. 2003, 55:579-581.
36. Chaplan S.R., Pogrel J.W., Yaksh T.L. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J. Pharmacol. Exp. Ther. 1994, 269:1117-1123.
37. Chen Y., Lu J., Pan H., Zhang Y., Wu H., Xu K., Liu X., Jiang Y., Bao X., Yao Z., Ding K., Lo W.H., Qiang B., Chan P., Shen Y., Wu X. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann. Neurol. 2003, 54:239-243.
38. Choe W., Messinger R.B., Leach E., Eckle V.S., Obradovic A., Salajegheh R., Jevtovic-Todorovic V., Todorovic S.M. TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent. Mol. Pharmacol. 2011, 80:900-910.
39. Christie S.B., Akins M.R., Schwob J.E., Fallon J.R. The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits. J. Neurosci. 2009, 29:1514-1524.
40. Cohen S.M., Li B., Tsien R.W., Ma H. Evolutionary and functional perspectives on signaling from neuronal surface to nucleus. Biochem. Biophys. Res. Commun. 2015, 460:88-99.
41. 2+ channel gene family. Circ. Res. 1998, 83:103-109.
42. Cross-disorder group of Psychiatric Genomics Consortium Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379.
43. Crowley J.J., Hilliard C.E., Kim Y., Morgan M.B., Lewis L.R., Muzny D.M., Hawes A.C., Sabo A., Wheeler D.A., Lieberman J.A., Sullivan P.F., Gibbs R.A. Deep resequencing and association analysis of schizophrenia candidate genes. Mol. Psychiatry 2013, 18:138-140.
44. Dao D.T., Mahon P.B., Cai X., Kovacsics C.E., Blackwell R.A., Arad M., Shi J., Zandi P.P., O'Donnell P., Knowles J.A., Weissman M.M., Coryell W., Scheftner W.A., Lawson W.B., Levinson D.F., Thompson S.M., Potash J.B., Gould T.D. Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biol. Psychiatry 2010, 68:801-810.
45. 2+ signals in sensory neurons. J. Neurosci. 2015, 35:5935-5940.
46. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 2001, 107:489-499.
47. Darnell J.C., Van Driesche S.J., Zhang C., Hung K.Y., Mele A., Fraser C.E., Stone E.F., Chen C., Fak J.J., Chi S.W., Licatalosi D.D., Richter J.D., Darnell R.B. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146:247-261.
48. Davis-Taber R.A., Scott V.E. Transcriptional profiling of dorsal root gangliain a neuropathic pain model using microarrayand laser capture microdissection. Drug Dev. Res. 2006, 67:308-330.
49. Del Pino I., Garcia-Frigola C., Dehorter N., Brotons-Mas J.R., Alvarez-Salvado E., Martinez de L.M., Ciceri G., Gabaldon M.V., Moratal D., Dierssen M., Canals S., Marin O., Rico B. Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron 2013, 79:1152-1168.
50. Deng P.Y., Rotman Z., Blundon J.A., Cho Y., Cui J., Cavalli V., Zakharenko S.S., Klyachko V.A. FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels. Neuron 2013, 77:696-711.
51. De Rubeis S., He X., Goldberg A.P., Poultney C.S., Samocha K., Cicek A.E., Kou Y., Liu L., Fromer M., Walker S., Singh T., Klei L., Kosmicki J., Shih-Chen F., Aleksic B., Biscaldi M., Bolton P.F., Brownfeld J.M., Cai J., Campbell N.G., Carracedo A., Chahrour M.H., Chiocchetti A.G., Coon H., Crawford E.L., Curran S.R., Dawson G., Duketis E., Fernandez B.A., Gallagher L., Geller E., Guter S.J., Hill R.S., Ionita-Laza J., Jimenz G.P., Kilpinen H., Klauck S.M., Kolevzon A., Lee I., Lei I., Lei J., Lehtimaki T., Lin C.F., Ma'ayan A., Marshall C.R., McInnes A.L., Neale B., Owen M.J., Ozaki N., Parellada M., Parr J.R., Purcell S., Puura K., Rajagopalan D., Rehnstrom K., Reichenberg A., Sabo A., Sachse M., Sanders S.J., Schafer C., Schulte-Ruther M., Skuse D., Stevens C., Szatmari P., Tammimies K., Valladares O., Voran A., Li-San W., Weiss L.A., Willsey A.J., Yu T.W., Yuen R.K., Cook E.H., Freitag C.M., Gill M., Hultman C.M., Lehner T., Palotie A., Schellenberg G.D., Sklar P., State M.W., Sutcliffe J.S., Walsh C.A., Scherer S.W., Zwick M.E., Barett J.C., Cutler D.J., Roeder K., Devlin B., Daly M.J., Buxbaum J.D. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014, 515:209-215.
52. Desarmenien M.G., Clendening B., Spitzer N.C. In vivo development of voltage-dependent ionic currents in embryonic Xenopus spinal neurons. J. Neurosci. 1993, 13:2575-2581.
53. Di Biase V., Tuluc P., Campiglio M., Obermair G.J., Heine M., Flucher B.E. Surface traffic of dendritic CaV1.2 calcium channels in hippocampal neurons. J. Neurosci. 2011, 31:13682-13694.
54. 2+ selectivity in the calmodulin regulation of CaV channels. Nature 2008, 451:830-834.
55. Di Forti M., Sallis H., Allegri F., Trotta A., Ferraro L., Stilo S.A., Marconi A., La C.C., Reis M.T., Pariante C., Dazzan P., Mondelli V., Paparelli A., Kolliakou A., Prata D., Gaughran F., David A.S., Morgan C., Stahl D., Khondoker M., Maccabe J.H., Murray R.M. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr. Bull. 2014, 40:1509-1517.
56. i. J. Neurosci. 2014, 34:7047-7058.
57. Doherty J.L., O'Donovan M.C., Owen M.J. Recent genomic advances in schizophrenia. Clin. Genet. 2012, 81:103-109.
58. Dolphin A.C. β subunits of voltage-gated calcium channels. J. Bioeng. Biomemb. 2003, 35:599-620.
59. Dolphin A.C. A short history of voltage-gated calcium channels. Br. J Pharmacol. 2006, 147(Suppl 1):S56-S62.
60. Dolphin A.C. Calcium channel auxiliary alpha(2)delta and beta subunits: trafficking and one step beyond. Nat. Rev. Neurosci. 2012, 13:542-555.
61. Edvardson S., Oz S., Abulhijaa F.A., Taher F.B., Shaag A., Zenvirt S., Dascal N., Elpeleg O. Early infantile epileptic encephalopathy associated with a high voltage gated calcium channelopathy. J. Med. Genet. 2013, 50:118-123.
62. 2 subunits of a DHP-sensitive calcium channel. Science 1988, 241:1661-1664.
63. Erk S., Meyer-Lindenberg A., Schnell K., Opitz von B.C., Esslinger C., Kirsch P., Grimm O., Arnold C., Haddad L., Witt S.H., Cichon S., Nothen M.M., Rietschel M., Walter H. Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch. Gen. Psychiatry 2010, 67:803-811.
64. 2+ channels. Nat. Neurosci. 2013, 16:1754-1763.
65. Eroglu C., Allen N.J., Susman M.W., O'Rourke N.A., Park C.Y., Ozkan E., Chakraborty C., Mulinyawe S.B., Annis D.S., Huberman A.D., Green E.M., LAWLER J., Dolmetsch R., Garcia K.C., Smith S.J., Luo Z.D., Rosenthal A., Mosher D.F., Barres B.A. Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 2009, 139:380-392.
66. 2+ channel blocker. Expert. Opin. Investig. Drugs 1997, 6:569-582.
67. 4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am. J. Hum. Genet. 2000, 66:1531-1539.
68. Etemad S., Obermair G.J., Bindreither D., Benedetti A., Stanika R., Di B.V., Burtscher V., Koschak A., Kofler R., Geley S., Wille A., Lusser A., Flockerzi V., Flucher B.E. Differential neuronal targeting of a new and two known calcium channel beta4 subunit splice variants correlates with their regulation of gene expression. J. Neurosci. 2014, 34:1446-1461.
69. Fabiato A. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J. Gen. Physiol. 1985, 85:247-289.
70. Fairless R., Masius H., Rohlmann A., Heupel K., Ahmad M., Reissner C., Dresbach T., Missler M. Polarized targeting of neurexins to synapses is regulated by their C-terminal sequences. J. Neurosci. 2008, 28:12969-12981.
71. Fatemi S.H., Folsom T.D. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr. Bull. 2009, 35:528-548.
72. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., Smoller J.W., Grozeva D., Stone J., Nikolov I., Chambert K., Hamshere M.L., Nimgaonkar V.L., Moskvina V., Thase M.E., Caesar S., Sachs G.S., Franklin J., Gordon-Smith K., Ardlie K.G., Gabriel S.B., Fraser C., Blumenstiel B., Defelice M., Breen G., Gill M., Morris D.W., Elkin A., Muir W.J., McGhee K.A., Williamson R., MacIntyre D.J., MacLean A.W., St C.D., Robinson M., Van B.M., Pereira A.C., Kandaswamy R., McQuillin A., Collier D.A., Bass N.J., Young A.H., Lawrence J., Ferrier I.N., Anjorin A., Farmer A., Curtis D., Scolnick E.M., McGuffin P., Daly M.J., Corvin A.P., Holmans P.A., Blackwood D.H., Gurling H.M., Owen M.J., Purcell S.M., Sklar P., Craddock N. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 2008, 40:1056-1058.
73. Ferron L., Nieto-Rostro M., Cassidy J.S., Dolphin A.C. Fragile X mental retardation protein controls synaptic vesicle exocytosis by modulating N-type calcium channel density. Nat. Commun. 2014, 5:3628.
74. Flanagan S.E., Patch A.M., Ellard S. Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet. Test. Mol. Biomarkers 2010, 14:533-537.
75. Fleckenstein A. History of calcium antagonists. Circ. Res. 1983, 52:I3-I16.
76. Fox A.P., Nowycky M.C., Tsien R.W. Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones. J. Physiol. (Lond.) 1987, 394:149-172.
77. Fox A.P., Nowycky M.C., Tsien R.W. Single-channel recordings of three types of calcium channels in chick sensory neurones. J. Physiol. (Lond.) 1987, 394:173-200.
78. Francois A., Kerckhove N., Meleine M., Alloui A., Barrere C., Gelot A., Uebele V.N., Renger J.J., Eschalier A., Ardid D., Bourinet E. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects. Pain 2013, 154:283-293.
79. Franke B., Vasquez A.A., Veltman J.A., Brunner H.G., Rijpkema M., Fernandez G. Genetic variation in CACNA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals. Biol. Psychiatry 2010, 68:586-588.
80. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., Carrera N., Humphreys I., Johnson J.S., Roussos P., Barker D.D., Banks E., Milanova V., Grant S.G., Hannon E., Rose S.A., Chambert K., Mahajan M., Scolnick E.M., Moran J.L., Kirov G., Palotie A., McCarroll S.A., Holmans P., Sklar P., Owen M.J., Purcell S.M., O'Donovan M.C. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506:179-184.
81. 2+ channel {alpha}2/{delta}-1 subunit. Am. J. Physiol Heart Circ. Physiol. 2009, 297:H117-H124.
82. Gao Z., Waggoner D., Stephens M., Ober C., Przeworski M. An estimate of the average number of recessive lethal mutations carried by humans. Genetics 2015, 199:1243-1254.
83. Gershon E.S., Grennan K., Busnello J., Badner J.A., Ovsiew F., Memon S., Alliey-Rodriguez N., Cooper J., Romanos B., Liu C. A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain. Mol. Psychiatry 2014, 19:890-894.
84. Gillis J., Burashnikov E., Antzelevitch C., Blaser S., Gross G., Turner L., Babul-Hirji R., Chitayat D. Long QT, syndactyly, joint contractures, stroke and novel CACNA1C mutation: expanding the spectrum of Timothy syndrome. Am. J. Med. Genet. A 2012, 158A:182-187.
85. Girirajan S., Dennis M.Y., Baker C., Malig M., Coe B.P., Campbell C.D., Mark K., Vu T.H., Alkan C., Cheng Z., Biesecker L.G., Bernier R., Eichler E.E. Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. Am. J. Hum. Genet. 2013, 92:221-237.
86. Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., Gordon-Smith K., Fraser C., Forty L., Russell E., Hamshere M.L., Moskvina V., Nikolov I., Farmer A., McGuffin P., Holmans P.A., Owen M.J., O'Donovan M.C., Craddock N. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry 2010, 15:1016-1022.
87. Green E.K., Hamshere M., Forty L., Gordon-Smith K., Fraser C., Russell E., Grozeva D., Kirov G., Holmans P., Moran J.L., Purcell S., Sklar P., Owen M.J., O'Donovan M.C., Jones L., Jones I.R., Craddock N. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol. Psychiatry 2013, 18:1302-1307.
88. Green E.K., Rees E., Walters J.T., Smith K.G., Forty L., Grozeva D., Moran J.L., Sklar P., Ripke S., Chambert K.D., Genovese G., McCarroll S.A., Jones I., Jones L., Owen M.J., O'Donovan M.C., Craddock N., Kirov G. Copy number variation in bipolar disorder. Mol. Psychiatry 2015, 10.1038/mp.2014.174.
89. Groen J.L., Andrade A., Ritz K., Jalalzadeh H., Haagmans M., Bradley T.E., Jongejan A., Verbeek D.S., Nurnberg P., Denome S., Hennekam R.C., Lipscombe D., Baas F., Tijssen M.A. CACNA1B mutation is linked to unique myoclonus-dystonia syndrome. Hum. Mol. Genet. 2015, 24:987-993.
90. Gu X., Olson E.C., Spitzer N.C. Spontaneous neuronal calcium spikes and waves during early differentiation. J. Neurosci. 1994, 14:6325-6335.
91. 2+ in developing Xenopus neurons. J. Neurosci. 1993, 13:4936-4948.
92. Guzman J.N., Sanchez-Padilla J., Chan C.S., Surmeier D.J. Robust pacemaking in substantia nigra dopaminergic neurons. J. Neurosci. 2009, 29:11011-11019.
93. Hall D.D., Dai S., Tseng P.Y., Malik Z., Nguyen M., Matt L., Schnizler K., Shephard A., Mohapatra D.P., Tsuruta F., Dolmetsch R.E., Christel C.J., Lee A., Burette A., Weinberg R.J., Hell J.W. Competition between alpha-actinin and Ca(2)(+)-calmodulin controls surface retention of the L-type Ca(2)(+) channel Ca(V)1.2. Neuron 2013, 78:483-497.
94. Hamshere M.L., Walters J.T., Smith R., Richards A.L., Green E., Grozeva D., Jones I., Forty L., Jones L., Gordon-Smith K., Riley B., O'Neill F.A., Kendler K.S., Sklar P., Purcell S., Kranz J., Morris D., Gill M., Holmans P., Craddock N., Corvin A., Owen M.J., O'Donovan M.C. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol. Psychiatry 2013, 18:708-712.
95. Hanson J.E., Madison D.V. Presynaptic FMR1 genotype influences the degree of synaptic connectivity in a mosaic mouse model of fragile X syndrome. J. Neurosci. 2007, 27:4014-4018.
96. Hell J.W., Westenbroek R.E., Warner C., Ahlijanian M.K., Prystay W., Gilbert M.M., Snutch T.P., Catterall W.A. Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel α1 subunits. J. Cell. Biol. 1993, 123:949-962.
97. Helton T.D., Xu W., Lipscombe D. Neuronal L-type calcium channels open quickly and are inhibited slowly. J. Neurosci. 2005, 25:10247-10251.
98. Hennessey J.A., Boczek N.J., Jiang Y.H., Miller J.D., Patrick W., Pfeiffer R., Sutphin B.S., Tester D.J., Barajas-Martinez H., Ackerman M.J., Antzelevitch C., Kanter R., Pitt G.S. A CACNA1C variant associated with reduced voltage-dependent inactivation, increased CaV1.2 channel window current, and arrhythmogenesis. PLoS ONE 2014, 9:e106982.
99. Hertzberg L., Katsel P., Roussos P., Haroutunian V., Domany E. Integration of gene expression and GWAS results supports involvement of calcium signaling in Schizophrenia. Schizophr. Res. 2015, 164:92-99.
100. 2+ channel β4 subunit. Proc. Natl. Acad. Sci. USA 2003, 100:307-312.
101. Hirtz J.J., Braun N., Griesemer D., Hannes C., Janz K., Lohrke S., Muller B., Friauf E. Synaptic refinement of an inhibitory topographic map in the auditory brainstem requires functional Cav1.3 calcium channels. J. Neurosci. 2012, 32:14602-14616.
102. Hoppa M., Lana B., Margas W., Dolphin A.C., Ryan T.A. α2δ couples calcium channels to neurotransmitter release sites to control release probability. Nature 2012, 486:122-125.
103. Hu C., Rusin C.G., Tan Z., Guagliardo N.A., Barrett P.Q. Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. J. Clin. Invest. 2012, 122:2046-2053.
104. Huang Z., Lujan R., Kadurin I., Uebele V.N., Renger J.J., Dolphin A.C., Shah M.M. Presynaptic HCN1 channels regulate Ca(V)3.2 activity and neurotransmission at select cortical synapses. Nat. Neurosci. 2011, 14:478-486.
105. International Schizophrenia Consortium Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241.
106. Iossifov I., O'Roak B.J., Sanders S.J., Ronemus M., Krumm N., Levy D., Stessman H.A., Witherspoon K.T., Vives L., Patterson K.E., Smith J.D., Paeper B., Nickerson D.A., Dea J., Dong S., Gonzalez L.E., Mandell J.D., Mane S.M., Murtha M.T., Sullivan C.A., Walker M.F., Waqar Z., Wei L., Willsey A.J., Yamrom B., Lee Y.H., Grabowska E., Dalkic E., Wang Z., Marks S., Andrews P., Leotta A., Kendall J., Hakker I., Rosenbaum J., Ma B., Rodgers L., Troge J., Narzisi G., Yoon S., Schatz M.C., Ye K., McCombie W.R., Shendure J., Eichler E.E., State M.W., Wigler M. The contribution of de novo coding mutations to autism spectrum disorder. Nature 2014, 515:216-221.
107. Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J., Yamrom B., Lee Y.H., Narzisi G., Leotta A., Kendall J., Grabowska E., Ma B., Marks S., Rodgers L., Stepansky A., Troge J., Andrews P., Bekritsky M., Pradhan K., Ghiban E., Kramer M., Parla J., Demeter R., Fulton L.L., Fulton R.S., Magrini V.J., Ye K., Darnell J.C., Darnell R.B., Mardis E.R., Wilson R.K., Schatz M.C., McCombie W.R., Wigler M. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74:285-299.
108. 2+ channels mediating synaptic transmission at the calyx of Held of mice. J. Physiol. 2005, 568:199-209.
109. Iwamoto K., Kakiuchi C., Bundo M., Ikeda K., Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol. Psychiatry 2004, 9:406-416.
110. Iwasaki S., Momiyama A., Uchitel O.D., Takahashi T. Developmental changes in calcium channel types mediating central synaptic transmission. J. Neurosci. 2000, 20:59-65.
111. Jay S.D., Ellis S.B., McCue A.F., Williams M.E., Vedvick T.S., Harpold M.M., Campbell K.P. Primary structure of the gamma subunit of the DHP-sensitive calcium channel from skeletal muscle. Science 1990, 248:490-492.
112. 2-subunit and the associated δ peptides. J. Biol. Chem. 1991, 266:3287-3293.
113. Jiang Y.H., Yuen R.K., Jin X., Wang M., Chen N., Wu X., Ju J., Mei J., Shi Y., He M., Wang G., Liang J., Wang Z., Cao D., Carter M.T., Chrysler C., Drmic I.E., Howe J.L., Lau L., Marshall C.R., Merico D., Nalpathamkalam T., Thiruvahindrapuram B., Thompson A., Uddin M., Walker S., Luo J., Anagnostou E., Zwaigenbaum L., Ring R.H., Wang J., Lajonchere C., Wang J., Shih A., Szatmari P., Yang H., Dawson G., Li Y., Scherer S.W. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am. J. Hum. Genet. 2013, 93:249-263.
114. Jouvenceau A., Eunson L.H., Spauschus A., Ramesh V., Zuberi S.M., Kullmann D.M., Hanna M.G. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 2001, 358:801-807.
115. Kanamori T., Kanai M.I., Dairyo Y., Yasunaga K., Morikawa R.K., Emoto K. Compartmentalized calcium transients trigger dendrite pruning in Drosophila sensory neurons. Science 2013, 340:1475-1478.
116. Keinan A., Clark A.G. Recent explosive human population growth has resulted in an excess of rare genetic variants. Science 2012, 336:740-743.
117. Kempton M.J., Ruberto G., Vassos E., Tatarelli R., Girardi P., Collier D., Frangou S. Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. Am. J. Psychiatry 2009, 166:1413-1414.
118. Khosravani H., Altier C., Simms B., Hamming K.S., Snutch T.P., Mezeyova J., Mcrory J.E., Zamponi G.W. Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy. J. Biol. Chem. 2004, 279:9681-9684.
119. Kimm T., Bean B.P. Inhibition of A-type potassium current by the peptide toxin SNX-482. J. Neurosci. 2014, 34:9182-9189.
120. Klassen T., Davis C., Goldman A., Burgess D., Chen T., Wheeler D., McPherson J., Bourquin T., Lewis L., Villasana D., Morgan M., Muzny D., Gibbs R., Noebels J. Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell 2011, 145:1036-1048.
121. Klemmer P., Meredith R.M., Holmgren C.D., Klychnikov O.I., Stahl-Zeng J., Loos M., Van der Schors R.C., Wortel J., Spijker S., Rotaru D.C., Mansvelder H.D., Smit A.B., Li K.W. Proteomics, ultrastructure and physiology of hippocampal synapses in a Fragile X Syndrome mouse model reveals pre-synaptic phenotype. J. Biol. Chem. 2011, 286:25495-25504.
122. Klugbauer N., Lacinova L., Marais E., Hobom M., Hofmann F. Molecular diversity of the calcium channel α2-δ subunit. J. Neurosci. 1999, 19:684-691.
123. 2+ channels activating at negative voltages. J. Biol. Chem. 2001, 276:22100-22106.
124. Krey J.F., Pasca S.P., Shcheglovitov A., Yazawa M., Schwemberger R., Rasmusson R., Dolmetsch R.E. Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat. Neurosci. 2013, 16:201-209.
125. Krueger D.D., Bear M.F. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu. Rev. Med. 2011, 62:411-429.
126. Lana B., Schlick B., Martin S., Pratt W.S., Page K.M., Goncalves L., Rahman W., Dickenson A.H., Bauer C.S., Dolphin A.C. Differential up-regulation in DRG neurons of an alphadelta-1 splice variant with a lower affinity for gabapentin after peripheral sensory nerve injury. Pain 2014, 155:522-533.
127. Lancaster T.M., Heerey E.A., Mantripragada K., Linden D.E. CACNA1C risk variant affects reward responsiveness in healthy individuals. Transl. Psychiatry 2014, 4:e461.
128. Lee A., Wang S., Williams B., Hagen J., Scheetz T.E., Haeseleer F. Characterization of Cav1.4 Complexes (alpha11.4, beta2, and alpha2delta4) in HEK293T Cells and in the retina. J. Biol. Chem. 2015, 290:1505-1521.
129. Lee A.S., Ra S., Rajadhyaksha A.M., Britt J.K., De Jesus-Cortes H., Gonzales K.L., Lee A., Moosmang S., Hofmann F., Pieper A.A., Rajadhyaksha A.M. Forebrain elimination of cacna1c mediates anxiety-like behavior in mice. Mol. Psychiatry 2012, 17:1054-1055.
130. Lee C., Scherer S.W. The clinical context of copy number variation in the human genome. Expert. Rev. Mol. Med. 2010, 12:e8.
131. Lee M. Z944: a first in class T-type calcium channel modulator for the treatment of pain. J. Peripher. Nerv. Syst. 2014, 19(Suppl 2):S11-S12.
132. Lee M.T., Chen C.H., Lee C.S., Chen C.C., Chong M.Y., Ouyang W.C., Chiu N.Y., Chuo L.J., Chen C.Y., Tan H.K., Lane H.Y., Chang T.J., Lin C.H., Jou S.H., Hou Y.M., Feng J., Lai T.J., Tung C.L., Chen T.J., Chang C.J., Lung F.W., Chen C.K., Shiah I.S., Liu C.Y., Teng P.R., Chen K.H., Shen L.J., Cheng C.S., Chang T.P., Li C.F., Chou C.H., Chen C.Y., Wang K.H., Fann C.S., Wu J.Y., Chen Y.T., Cheng A.T. Genome-wide association study of bipolar I disorder in the Han Chinese population. Mol. Psychiatry 2011, 16:548-556.
133. Lee S.H., Ripke S., Neale B.M., Faraone S.V., Purcell S.M., Perlis R.H., Mowry B.J., Thapar A., Goddard M.E., Witte J.S., Absher D., Agartz I., Akil H., Amin F., Andreassen O.A., Anjorin A., Anney R., Anttila V., Arking D.E., Asherson P., Azevedo M.H., Backlund L., Badner J.A., Bailey A.J., Banaschewski T., Barchas J.D., Barnes M.R., Barrett T.B., Bass N., Battaglia A., Bauer M., Bayes M., Bellivier F., Bergen S.E., Berrettini W., Betancur C., Bettecken T., Biederman J., Binder E.B., Black D.W., Blackwood D.H., Bloss C.S., Boehnke M., Boomsma D.I., Breen G., Breuer R., Bruggeman R., Cormican P., Buccola N.G., Buitelaar J.K., Bunney W.E., Buxbaum J.D., Byerley W.F., Byrne E.M., Caesar S., Cahn W., Cantor R.M., Casas M., Chakravarti A., Chambert K., Choudhury K., Cichon S., Cloninger C.R., Collier D.A., Cook E.H., Coon H., Cormand B., Corvin A., Coryell W.H., Craig D.W., Craig I.W., Crosbie J., Cuccaro M.L., Curtis D., Czamara D., Datta S., Dawson G., Day R., De Geus E.J., Degenhardt F., Djurovic S., Donohoe G.J., Doyle A.E., Duan J., Dudbridge F., Duketis E., Ebstein R.P., Edenberg H.J., Elia J., Ennis S., Etain B., Fanous A., Farmer A.E., Ferrier I.N., Flickinger M., Fombonne E., Foroud T., Frank J., Franke B., Fraser C., Freedman R., Freimer N.B., Freitag C.M., Friedl M., Frisen L., Gallagher L., Gejman P.V., Georgieva L., Gershon E.S., Geschwind D.H., Giegling I., Gill M., Gordon S.D., Gordon-Smith K., Green E.K., Greenwood T.A., Grice D.E., Gross M., Grozeva D., Guan W., Gurling H., De H.L., Haines J.L., Hakonarson H., Hallmayer J., Hamilton S.P., Hamshere M.L., Hansen T.F., Hartmann A.M., Hautzinger M., Heath A.C., Henders A.K., Herms S., Hickie I.B., Hipolito M., Hoefels S., Holmans P.A., Holsboer F., Hoogendijk W.J., Hottenga J.J., Hultman C.M., Hus V., Ingason A., Ising M., Jamain S., Jones E.G., Jones I., Jones L., Tzeng J.Y., Kahler A.K., Kahn R.S., Kandaswamy R., Keller M.C., Kennedy J.L., Kenny E., Kent L., Kim Y., Kirov G.K., Klauck S.M., Klei L., Knowles J.A., Kohli M.A., Koller D.L., Konte B., Korszun A., Krabbendam L., Krasucki R., Kuntsi J., Kwan P., Landen M., Langstrom N., Lathrop M., Lawrence J., Lawson W.B., Leboyer M., Ledbetter D.H., Lee P.H., Lencz T., Lesch K.P., Levinson D.F., Lewis C.M., Li J., Lichtenstein P., Lieberman J.A., Lin D.Y., Linszen D.H., Liu C., Lohoff F.W., Loo S.K., Lord C., Lowe J.K., Lucae S., MacIntyre D.J., Madden P.A., Maestrini E., Magnusson P.K., Mahon P.B., Maier W., Malhotra A.K., Mane S.M., Martin C.L., Martin N.G., Mattheisen M., Matthews K., Mattingsdal M., McCarroll S.A., McGhee K.A., McGough J.J., McGrath P.J., McGuffin P., McInnis M.G., McIntosh A., McKinney R., McLean A.W., McMahon F.J., McMahon W.M., McQuillin A., Medeiros H., Medland S.E., Meier S., Melle I., Meng F., Meyer J., Middeldorp C.M., Middleton L., Milanova V., Miranda A., Monaco A.P., Montgomery G.W., Moran J.L., Moreno-De-Luca D., Morken G., Morris D.W., Morrow E.M., Moskvina V., Muglia P., Muhleisen T.W., Muir W.J., Muller-Myhsok B., Murtha M., MYERS R.M., Myin-Germeys I., Neale M.C., Nelson S.F., Nievergelt C.M., Nikolov I., Nimgaonkar V., Nolen W.A., Nothen M.M., Nurnberger J.I., Nwulia E.A., Nyholt D.R., O'Dushlaine C., Oades R.D., Olincy A. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 2013, 45:984-994.
134. Lepski G., Jannes C.E., Nikkhah G., Bischofberger J. cAMP promotes the differentiation of neural progenitor cells in vitro via modulation of voltage-gated calcium channels. Front Cell Neurosci. 2013, 7:155.
135. Leroy J., Richards M.S., Butcher A.J., Nieto-Rostro M., Pratt W.S., Davies A., Dolphin A.C. Interaction via a key tryptophan in the I-II linker of N-type calcium channels is required for beta1 but not for palmitoylated beta2, implicating an additional binding site in the regulation of channel voltage-dependent properties. J. Neurosci. 2005, 25:6984-6996.
136. Lewis B.B., Miller L.E., Herbst W.A., Saha M.S. The role of voltage-gated calcium channels in neurotransmitter phenotype specification: coexpression and functional analysis in Xenopus laevis. J. Comp. Neurol. 2014, 522:2518-2531.
137. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., Williams N.M., Schwab S.G., Pulver A.E., Faraone S.V., Brzustowicz L.M., Kaufmann C.A., Garver D.L., Gurling H.M., Lindholm E., Coon H., Moises H.W., Byerley W., Shaw S.H., Mesen A., Sherrington R., O'Neill F.A., Walsh D., Kendler K.S., Ekelund J., Paunio T., Lonnqvist J., Peltonen L., O'Donovan M.C., Owen M.J., Wildenauer D.B., Maier W., Nestadt G., Blouin J.L., Antonarakis S.E., Mowry B.J., Silverman J.M., Crowe R.R., Cloninger C.R., Tsuang M.T., Malaspina D., Harkavy-Friedman J.M., Svrakic D.M., Bassett A.S., Holcomb J., Kalsi G., McQuillin A., Brynjolfson J., Sigmundsson T., Petursson H., Jazin E., Zoega T., Helgason T. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am. J. Hum. Genet. 2003, 73:34-48.
138. Lewis D.A. The chandelier neuron in schizophrenia. Dev. Neurobiol. 2011, 71:118-127.
139. Li C.Y., Zhang X.L., Matthews E.A., Li K.W., Kurwa A., Boroujerdi A., Gross J., Gold M.S., Dickenson A.H., Feng G., Luo Z.D. Calcium channel alpha(2)delta(1) subunit mediates spinal hyperexcitability in pain modulation. Pain 2006, 125:20-34.
140. Lipscombe D., Madison D.V., Poenie M., Reuter H., Tsien R.Y., Tsien R.W. Spatial distribution of calcium channels and cytosolic calcium transients in growth cones and cell bodies of sympathetic neurons. Proc. Natl. Acad. Sci. USA 1988, 85:2398-2402.
141. 2+ channel. J. Biol. Chem. 1996, 271:13804-13810.
142. Liu L.X., Burgess L.H., Gonzalez A.M., Sibley D.R., Chiodo L.A. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins. Synapse 1999, 31:108-118.
143. Liu Y., Harding M., Pittman A., Dore J., Striessnig J., Rajadhyaksha A., Chen X. Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area. J. Neurophysiol. 2014, 112:1119-1130.
144. Lu A.T., Dai X., Martinez-Agosto J.A., Cantor R.M. Support for calcium channel gene defects in autism spectrum disorders. Mol. Autism 2012, 3:18.
145. 2δ calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J. Neurosci. 2001, 21:1868-1875.
146. Ma H., Cohen S., Li B., Tsien R.W. Exploring the dominant role of Cav1 channels in signalling to the nucleus. Biosci. Rep. 2013, 33:97-101.
147. MacArthur D.G., Balasubramanian S., Frankish A., Huang N., Morris J., Walter K., Jostins L., Habegger L., Pickrell J.K., Montgomery S.B., Albers C.A., Zhang Z.D., Conrad D.F., Lunter G., Zheng H., Ayub Q., DePristo M.A., Banks E., Hu M., Handsaker R.E., Rosenfeld J.A., Fromer M., Jin M., Mu X.J., Khurana E., Ye K., Kay M., Saunders G.I., Suner M.M., Hunt T., Barnes I.H., Amid C., Carvalho-Silva D.R., Bignell A.H., Snow C., Yngvadottir B., Bumpstead S., Cooper D.N., Xue Y., Romero I.G., Wang J., Li Y., Gibbs R.A., McCarroll S.A., Dermitzakis E.T., Pritchard J.K., Barrett J.C., Harrow J., Hurles M.E., Gerstein M.B., Tyler-Smith C. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012, 335:823-828.
148. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012, 148:1223-1241.
149. 2+ channels in cardiac pacemaker activity. Proc. Natl. Acad. Sci. USA 2003, 100:5543-5548.
150. Mansergh F., Orton N.C., Vessey J.P., Lalonde M.R., Stell W.K., Tremblay F., Barnes S., Rancourt D.E., Bech-Hansen N.T. Mutation of the calcium channel gene Cacna1f disrupts calcium signaling, synaptic transmission and cellular organization in mouse retina. Hum. Mol. Genet. 2005, 14:3035-3046.
151. Marek K.W., Kurtz L.M., Spitzer N.C. cJun integrates calcium activity and tlx3 expression to regulate neurotransmitter specification. Nat. Neurosci. 2010, 13:944-950.
152. McDonough S.I., Swartz K.J., Mintz I.M., Boland L.M., Bean B.P. Inhibition of calcium channels in rat central and peripheral neurons by omega-conotoxin MVIIC. J. Neurosci. 1996, 16:2612-2623.
153. McKinney B.C., Sze W., Lee B., Murphy G.G. Impaired long-term potentiation and enhanced neuronal excitability in the amygdala of Ca(V)1.3 knockout mice. Neurobiol. Learn. Mem. 2009, 92:519-528.
154. Meir A., Bell D.C., Stephens G.J., Page K.M., Dolphin A.C. Calcium channel β subunit promotes voltage-dependent modulation of α1B by Gβγ. Biophys. J. 2000, 79:731-746.
155. Mencacci N.E., R'bibo L., Bandres-Ciga S., Carecchio M., Zorzi G., Nardocci N., Garavaglia B., Batla A., Bhatia K.P., Pittman A.M., Hardy J., Weissbach A., Klein C., Gasser T., Lohmann E., Wood N.W. The CACNA1B R1389H variant is not associated with myoclonus-dystonia in a large European multicentric cohort. Hum. Mol. Genet. 2015, 24:5326-5329.
156. Mezghrani A., Monteil A., Watschinger K., Sinnegger-Brauns M.J., Barrere C., Bourinet E., Nargeot J., Striessnig J., Lory P. A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels. J. Neurosci. 2008, 28:4501-4511.
157. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., St Clair D.M., Muir W.J., Blackwood D.H., Porteous D.J. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 2000, 9:1415-1423.
158. Mintz I.M., Adams M.E., Bean B.P. P-type calcium channels in rat central and peripheral neurons. Neuron 1992, 9:85-95.
159. Mintz I.M., Venema V.J., Swiderek K.M., Lee T.D., Bean B.P., Adams M.E. P-type calcium channels blocked by the spider toxin w-Aga-IVA. Nature 1992, 355:827-829.
160. Mire E., Mezzera C., Leyva-Diaz E., Paternain A.V., Squarzoni P., Bluy L., Castillo-Paterna M., Lopez M.J., Peregrin S., Tessier-Lavigne M., Garel S., Galceran J., Lerma J., Lopez-Bendito G. Spontaneous activity regulates Robo1 transcription to mediate a switch in thalamocortical axon growth. Nat. Neurosci. 2012, 15:1134-1143.
161. 2+ channels by Ro 40-5967. Circ. Res. 1994, 75:144-148.
162. 2+ channels to synaptic vesicle exocytosis. Nature 2003, 424:939-948.
163. Mitchell K.J. The genetics of neurodevelopmental disease. Curr. Opin. Neurobiol. 2011, 21:197-203.
164. 2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J. Neurosci. 2005, 25:9883-9892.
165. V2.2 calcium channel expression. EMBO J. 2002, 21:1514-1523.
166. Müller C.S., Haupt A., Bildl W., Schindler J., Knaus H.G., Meissner M., Rammner B., Striessnig J., Flockerzi V., Fakler B., Schulte U. Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain. PNAS 2010, 107:14950-14957.
167. Nakamura Y., Harada H., Kamasawa N., Matsui K., Rothman J.S., Shigemoto R., Silver R.A., DiGregorio D.A., Takahashi T. Nanoscale distribution of presynaptic Ca(2+) channels and its impact on vesicular release during development. Neuron 2015, 85:145-158.
168. Neely G.G., Hess A., Costigan M., Keene A.C., Goulas S., Langeslag M., Griffin R.S., Belfer I., Dai F., Smith S.B., Diatchenko L., Gupta V., Xia C.P., Amann S., Kreitz S., Heindl-Erdmann C., Wolz S., Ly C.V., Arora S., Sarangi R., Dan D., Novatchkova M., Rosenzweig M., Gibson D.G., Truong D., Schramek D., Zoranovic T., Cronin S.J., Angjeli B., Brune K., Dietzl G., Maixner W., Meixner A., Thomas W., Pospisilik J.A., Alenius M., Kress M., Subramaniam S., Garrity P.A., Bellen H.J., Woolf C.J., Penninger J.M. A genome-wide Drosophila screen for heat nociception identifies alpha2delta3 as an evolutionarily conserved pain gene. Cell 2010, 143:628-638.
169. Newcomb R., Szoke B., Palma A., Wang G., Chen X.H., Hopkins W., Cong R., Miller J., Urge L., Tarczy-Hornoch K., Loo J.A., Dooley D.J., Nadasdi L., Tsien R.W., Lemos J., Miljanich G. Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas. Biochemistry 1998, 37:15353-15362.
170. Newton R.A., Bingham S., Case P.C., Sanger G.J., Lawson S.N. Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta-1 subunit following partial sciatic nerve injury. Brain Res. Mol. Brain Res. 2001, 95:1-8.
171. Nilius B., Hess P., Lansman J.B., Tsien R.W. A novel type of cardiac calcium channel in ventricular cells. Nature 1985, 316:443-446.
172. Nishiyama M., Togashi K., von Schimmelmann M.J., Lim C.S., Maeda S., Yamashita N., Goshima Y., Ishii S., Hong K. Semaphorin 3A induces CaV2.3 channel-dependent conversion of axons to dendrites. Nat. Cell Biol. 2011, 13:676-685.
173. Nowycky M.C., Fox A.P., Tsien R.W. Long-opening mode of gating of neuronal calcium channels and its promotion by the dihydropyridine calcium agonist Bay K 8644. Proc. Natl. Acad. Sci. USA 1985, 82:2178-2182.
174. Nowycky M.C., Fox A.P., Tsien R.W. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 1985, 316:440-446.
175. Nurnberger J.I., Koller D.L., Jung J., Edenberg H.J., Foroud T., Guella I., Vawter M.P., Kelsoe J.R. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry 2014, 71:657-664.
176. O'Dushlaine C., Kenny E., Heron E., Donohoe G., Gill M., Morris D., Corvin A. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol. Psychiatry 2011, 16:286-292.
177. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., Turner E.H., Stanaway I.B., Vernot B., Malig M., Baker C., Reilly B., Akey J.M., Borenstein E., Rieder M.J., Nickerson D.A., Bernier R., Shendure J., Eichler E.E. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
178. 2+ channel gene CACNL1A4. Cell 1996, 87:543-552.
179. Owen M.J. New approaches to psychiatric diagnostic classification. Neuron 2014, 84:564-571.
180. Page K.M., Heblich F., Davies A., Butcher A.J., Leroy J., Bertaso F., Pratt W.S., Dolphin A.C. Dominant-negative calcium channel suppression by truncated constructs involves a kinase implicated in the unfolded protein response. J. Neurosci. 2004, 24:5400-5409.
181. Page K.M., Heblich F., Margas W., Pratt W.S., Chaggar K., Sandhu K., Davies A., Dolphin A.C. The N-terminus is key to dominant-negative suppression of Cav2 channels: implications for episodic ataxia-2. J. Biol. Chem. 2010, 285:835-844.
182. Parajuli L.K., Nakajima C., Kulik A., Matsui K., Schneider T., Shigemoto R., Fukazawa Y. Quantitative regional and ultrastructural localization of the Ca(v)2.3 subunit of R-type calcium channel in mouse brain. J. Neurosci. 2012, 32:13555-13567.
183. Pasca S.P., Portmann T., Voineagu I., Yazawa M., Shcheglovitov A., Pasca A.M., Cord B., Palmer T.D., Chikahisa S., Nishino S., Bernstein J.A., Hallmayer J., Geschwind D.H., Dolmetsch R.E. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat. Med. 2011, 17:1657-1662.
184. Patel R., Bauer C.S., Nieto-Rostro M., Margas W., Ferron L., Chaggar K., Crews K., Ramirez J.D., Bennett D.L., Schwartz A., Dickenson A.H., Dolphin A.C. α2δ-1 gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage. J. Neurosci. 2013, 33:16412-16426.
185. Paulus F.M., Bedenbender J., Krach S., Pyka M., Krug A., Sommer J., Mette M., Nothen M.M., Witt S.H., Rietschel M., Kircher T., Jansen A. Association of rs1006737 in CACNA1C with alterations in prefrontal activation and fronto-hippocampal connectivity. Hum. Brain Mapp. 2014, 35:1190-1200.
186. Perez-Reyes E. Molecular characterization of a novel family of low voltage-activated T-type, calcium channels. J. Bioenerg. Biomembr. 1998, 30:313-318.
187. Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol. Rev. 2003, 83:117-161.
188. 2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J. Pharmacol. Exp. Ther. 2009, 328:621-627.
189. Pietrobon D. CaV2.1 channelopathies. Pflugers Arch. 2010, 460:375-393.
190. Pietrobon D., Moskowitz M.A. Pathophysiology of migraine. Annu. Rev. Physiol. 2013, 75:365-391.
191. Pinggera A., Lieb A., Benedetti B., Lampert M., Monteleone S., Liedl K.R., Tuluc P., Striessnig J. CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels. Biol. Psychiatry 2015, 77:816-822.
192. Pinto D., Delaby E., Merico D., Barbosa M., Merikangas A., Klei L., Thiruvahindrapuram B., Xu X., Ziman R., Wang Z., Vorstman J.A., Thompson A., Regan R., Pilorge M., Pellecchia G., Pagnamenta A.T., Oliveira B., Marshall C.R., Magalhaes T.R., Lowe J.K., Howe J.L., Griswold A.J., Gilbert J., Duketis E., Dombroski B.A., De Jonge M.V., Cuccaro M., Crawford E.L., Correia C.T., Conroy J., Conceicao I.C., Chiocchetti A.G., Casey J.P., Cai G., Cabrol C., Bolshakova N., Bacchelli E., Anney R., Gallinger S., Cotterchio M., Casey G., Zwaigenbaum L., Wittemeyer K., Wing K., Wallace S., Van E.H., Tryfon A., Thomson S., Soorya L., Roge B., Roberts W., Poustka F., Mouga S., Minshew N., McInnes L.A., McGrew S.G., Lord C., Leboyer M., Le Couteur A.S., Kolevzon A., Jimenez G.P., Jacob S., Holt R., Guter S., Green J., Green A., Gillberg C., Fernandez B.A., Duque F., Delorme R., Dawson G., Chaste P., Cafe C., Brennan S., Bourgeron T., Bolton P.F., Bolte S., Bernier R., Baird G., Bailey A.J., Anagnostou E., Almeida J., Wijsman E.M., Vieland V.J., Vicente A.M., Schellenberg G.D., Pericak-Vance M., Paterson A.D., Parr J.R., Oliveira G., Nurnberger J.I., Monaco A.P., Maestrini E., Klauck S.M., Hakonarson H., Haines J.L., Geschwind D.H., Freitag C.M., Folstein S.E., Ennis S., Coon H., Battaglia A., Szatmari P., Sutcliffe J.S., Hallmayer J., Gill M., Cook E.H., Buxbaum J.D., Devlin B., Gallagher L., Betancur C., Scherer S.W. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am. J. Hum. Genet. 2014, 94:677-694.
193. Pippucci T., Parmeggiani A., Palombo F., Maresca A., Angius A., Crisponi L., Cucca F., Liguori R., Valentino M.L., Seri M., Carelli V. A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy. PLoS ONE 2013, 8:e82154.
194. Pirone A., Kurt S., Zuccotti A., Ruttiger L., Pilz P., Brown D.H., Franz C., Schweizer M., Rust M.B., Rubsamen R., Friauf E., Knipper M., Engel J. alpha2delta3 is essential for normal structure and function of auditory nerve synapses and is a novel candidate for auditory processing disorders. J. Neurosci. 2014, 34:434-445.
195. 2+ channels. Cell 2000, 102:89-97.
196. 1-subunit. Nature 1994, 368:67-70.
197. Price T.J., Flores C.M., Cervero F., Hargreaves K.M. The RNA binding and transport proteins staufen and fragile X mental retardation protein are expressed by rat primary afferent neurons and localize to peripheral and central axons. Neuroscience 2006, 141:2107-2116.
198. Price T.J., Rashid M.H., Millecamps M., Sanoja R., Entrena J.M., Cervero F. Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR. J. Neurosci. 2007, 27:13958-13967.
199. Purcell S.M., Moran J.L., Fromer M., Ruderfer D., Solovieff N., Roussos P., O'Dushlaine C., Chambert K., Bergen S.E., Kahler A., Duncan L., Stahl E., Genovese G., Fernandez E., Collins M.O., Komiyama N.H., Choudhary J.S., Magnusson P.K., Banks E., Shakir K., Garimella K., Fennell T., DePristo M., Grant S.G., Haggarty S.J., Gabriel S., Scolnick E.M., Lander E.S., Hultman C.M., Sullivan P.F., McCarroll S.A., Sklar P. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014, 506:185-190.
200. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
201. 2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons. J. Neurosci. 2009, 29:15414-15419.
202. v2.2 induced by truncated constructs. J. Neurosci. 2001, 21:8495-8504.
203. 2+ channels regulates mandibular development. J. Clin. Invest. 2013, 123:1638-1646.
204. Rees E., Walters J.T., Georgieva L., Isles A.R., Chambert K.D., Richards A.L., Mahoney-Davies G., Legge S.E., Moran J.L., McCarroll S.A., O'Donovan M.C., Owen M.J., Kirov G. Analysis of copy number variations at 15 schizophrenia-associated loci. Br. J. Psychiatry 2014, 204:108-114.
205. Reynolds I.J., Wagner J.A., Snyder S.H., Thayer S.A., Olivera B.M., Miller R.J. Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA. Proc. Natl. Acad. Sci. USA 1986, 83:8804-8807.
206. 1A-voltage-dependent calcium channel gene. Hum. Mol. Genet. 1997, 6:1289-1293.
207. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kahler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., Kim Y., Lee S.H., Magnusson P.K., Sanchez N., Stahl E.A., Williams S., Wray N.R., Xia K., Bettella F., Borglum A.D., Bulik-Sullivan B.K., Cormican P., Craddock N., de L.C., Durmishi N., Gill M., Golimbet V., Hamshere M.L., Holmans P., Hougaard D.M., Kendler K.S., Lin K., Morris D.W., Mors O., Mortensen P.B., Neale B.M., O'Neill F.A., Owen M.J., Milovancevic M.P., Posthuma D., Powell J., Richards A.L., Riley B.P., Ruderfer D., Rujescu D., Sigurdsson E., Silagadze T., Smit A.B., Stefansson H., Steinberg S., Suvisaari J., Tosato S., Verhage M., Walters J.T., Levinson D.F., Gejman P.V., Kendler K.S., Laurent C., Mowry B.J., O'Donovan M.C., Owen M.J., Pulver A.E., Riley B.P., Schwab S.G., Wildenauer D.B., Dudbridge F., Holmans P., Shi J., Albus M., Alexander M., Campion D., Cohen D., Dikeos D., Duan J., Eichhammer P., Godard S., Hansen M., Lerer F.B., Liang K.Y., Maier W., Mallet J., Nertney D.A., Nestadt G., Norton N., O'Neill F.A., Papadimitriou G.N., Ribble R., Sanders A.R., Silverman J.M., Walsh D., Williams N.M., Wormley B., Arranz M.J., Bakker S., Bender S., Bramon E., Collier D., Crespo-Facorro B., Hall J., Iyegbe C., Jablensky A., Kahn R.S., Kalaydjieva L., Lawrie S., Lewis C.M., Lin K., Linszen D.H., Mata I., McIntosh A., Murray R.M., Ophoff R.A., Powell J., Rujescu D., Van O.J., Walshe M., Weisbrod M., Wiersma D., Donnelly P., Barroso I., Blackwell J.M., Bramon E., Brown M.A., Casas J.P., Corvin A.P., Deloukas P., Duncanson A., Jankowski J., Markus H.S., Mathew C.G., Palmer C.N., Plomin R., Rautanen A., Sawcer S.J., Trembath R.C., Viswanathan A.C., Wood N.W., Spencer C.C., Band G., Bellenguez C., Freeman C., Hellenthal G., Giannoulatou E., Pirinen M., Pearson R.D., Strange A., Su Z., Vukcevic D., Donnelly P., Langford C., Hunt S.E., Edkins S., Gwilliam R., Blackburn H., Bumpstead S.J., Dronov S., Gillman M., Gray E., Hammond N., Jayakumar A., McCann O.T., Liddle J., Potter S.C., Ravindrarajah R., Ricketts M., Tashakkori-Ghanbaria A., Waller M.J., Weston P., Widaa S., Whittaker P., Barroso I., Deloukas P., Mathew C.G., Blackwell J.M., Brown M.A., Corvin A.P., McCarthy M.I., Spencer C.C., Bramon E., Corvin A.P., O'Donovan M.C., Stefansson K., Scolnick E., Purcell S., McCarroll S.A., Sklar P., Hultman C.M., Sullivan P.F. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 2013, 45:1150-1159.
208. Rivas M.A., Pirinen M., Conrad D.F., Lek M., Tsang E.K., Karczewski K.J., Maller J.B., Kukurba K.R., DeLuca D.S., Fromer M., Ferreira P.G., Smith K.S., Zhang R., Zhao F., Banks E., Poplin R., Ruderfer D.M., Purcell S.M., Tukiainen T., Minikel E.V., Stenson P.D., Cooper D.N., Huang K.H., Sullivan T.J., Nedzel J., Bustamante C.D., Li J.B., Daly M.J., Guigo R., Donnelly P., Ardlie K., Sammeth M., Dermitzakis E.T., McCarthy M.I., Montgomery S.B., Lappalainen T., MacArthur D.G. Effect of predicted protein-truncating genetic variants on the human transcriptome. Science 2015, 348:666-669.
209. Ronesi J.A., Huber K.M. Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse. Sci. Signal. 2008, 1:e6.
210. Rosenberg S.S., Spitzer N.C. Calcium signaling in neuronal development. Cold Spring Harb. Perspect. Biol. 2011, 3:a004259.
211. Roussos P., Mitchell A.C., Voloudakis G., Fullard J.F., Pothula V.M., Tsang J., Stahl E.A., Georgakopoulos A., Ruderfer D.M., Charney A., Okada Y., Siminovitch K.A., Worthington J., Padyukov L., Klareskog L., Gregersen P.K., Plenge R.M., Raychaudhuri S., Fromer M., Purcell S.M., Brennand K.J., Robakis N.K., Schadt E.E., Akbarian S., Sklar P. A role for noncoding variation in schizophrenia. Cell Rep. 2014, 9:1417-1429.
212. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43:969-976.
213. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427.
214. Scholl U.I., Goh G., Stolting G., de Oliveira R.C., Choi M., Overton J.D., Fonseca A.L., Korah R., Starker L.F., Kunstman J.W., Prasad M.L., Hartung E.A., Mauras N., Benson M.R., Brady T., Shapiro J.R., Loring E., Nelson-Williams C., Libutti S.K., Mane S., Hellman P., Westin G., Akerstrom G., Bjorklund P., Carling T., Fahlke C., Hidalgo P., Lifton R.P. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat. Genet. 2013, 45:1050-1054.
215. Scholl U.I., Stolting G., Nelson-Williams C., Vichot A.A., Choi M., Loring E., Prasad M.L., Goh G., Carling T., Juhlin C.C., Quack I., Rump L.C., Thiel A., Lande M., Frazier B.G., Rasoulpour M., Bowlin D.L., Sethna C.B., Trachtman H., Fahlke C., Lifton R.P. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife 2015, 4:e06315.
216. Sinnegger-Brauns M.J., Huber I.G., Koschak A., Wild C., Obermair G.J., Einzinger U., Hoda J.C., Sartori S.B., Striessnig J. Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol. Pharmacol. 2009, 75:407-414.
217. Smolin B., Karry R., Gal-Ben-Ari S., Ben-Shachar D. Differential expression of genes encoding neuronal ion-channel subunits in major depression, bipolar disorder and schizophrenia: implications for pathophysiology. Int. J. Neuropsychopharmacol. 2012, 15:869-882.
218. Soong T.W., Stea A., Hodson C.D., Dubel S.J., Vincent S.R., Snutch T.P. Structure and functional expression of a member of the low voltage-activated calcium channel family. Science 1993, 260:1133-1136.
219. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., Napolitano C., Schwartz P.J., Joseph R.M., Condouris K., Tager-Flusberg H., Priori S.G., Sanguinetti M.C., Keating M.T. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31.
220. Splawski I., Yoo D.S., Stotz S.C., Cherry A., Clapham D.E., Keating M.T. CACNA1H mutations in autism spectrum disorders. J. Biol. Chem. 2006, 281:22085-22091.
221. Staats P.S., Yearwood T., Charapata S.G., Presley R.W., Wallace M.S., Byas-Smith M., Fisher R., Bryce D.A., Mangieri E.A., Luther R.R., Mayo M., McGuire D., Ellis D. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 2004, 291:63-70.
222. 1A calcium channel reflect similarities to neuronal Q- and P-type channels. Proc. Natl. Acad. Sci. USA 1994, 91:10576-10580.
223. 2+ channels. Proc. Natl. Acad. Sci. USA 1990, 87:9108-9112.
224. 3H]azidopine within the α1 subunit. Proc. Natl. Acad. Sci. USA 1991, 88:10769-10773.
225. Striessnig J., Ortner N.J., Pinggera A. Pharmacology of L-type calcium channels: novel drugs for old targets?. Curr. Mol. Pharmacol. 2015, 67:821-870.
226. Striessnig J., Pinggera A., Kaur G., Bock G., Tuluc P. L-type Ca channels in heart and brain. Wiley Interdiscip. Rev. Membr. Transp. Signal. 2014, 3:15-38.
227. Strom S.P., Stone J.L., Ten Bosch J.R., Merriman B., Cantor R.M., Geschwind D.H., Nelson S.F. High-density SNP association study of the 17q21 chromosomal region linked to autism identifies CACNA1G as a novel candidate gene. Mol. Psychiatry 2010, 15:996-1005.
228. Sulem P., Helgason H., Oddson A., Stefansson H., Gudjonsson S.A., Zink F., Hjartarson E., Sigurdsson G.T., Jonasdottir A., Jonasdottir A., Sigurdsson A., Magnusson O.T., Kong A., Helgason A., Holm H., Thorsteinsdottir U., Masson G., Gudbjartsson D.F., Stefansson K. Identification of a large set of rare complete human knockouts. Nat. Genet. 2015, 47:448-452.
229. Szatmari P., Paterson A.D., Zwaigenbaum L., Roberts W., Brian J., Liu X.Q., Vincent J.B., Skaug J.L., Thompson A.P., Senman L., Feuk L., Qian C., Bryson S.E., Jones M.B., Marshall C.R., Scherer S.W., Vieland V.J., Bartlett C., Mangin L.V., Goedken R., Segre A., Pericak-Vance M.A., Cuccaro M.L., Gilbert J.R., Wright H.H., Abramson R.K., Betancur C., Bourgeron T., Gillberg C., Leboyer M., Buxbaum J.D., Davis K.L., Hollander E., Silverman J.M., Hallmayer J., Lotspeich L., Sutcliffe J.S., Haines J.L., Folstein S.E., Piven J., Wassink T.H., Sheffield V., Geschwind D.H., Bucan M., Brown W.T., Cantor R.M., Constantino J.N., Gilliam T.C., Herbert M., Lajonchere C., Ledbetter D.H., Lese-Martin C., Miller J., Nelson S., Samango-Sprouse C.A., Spence S., State M., Tanzi R.E., Coon H., Dawson G., Devlin B., Estes A., Flodman P., Klei L., McMahon W.M., Minshew N., Munson J., Korvatska E., Rodier P.M., Schellenberg G.D., Smith M., Spence M.A., Stodgell C., Tepper P.G., Wijsman E.M., Yu C.E., Roge B., Mantoulan C., Wittemeyer K., Poustka A., Felder B., Klauck S.M., Schuster C., Poustka F., Bolte S., Feineis-Matthews S., Herbrecht E., Schmotzer G., Tsiantis J., Papanikolaou K., Maestrini E., Bacchelli E., Blasi F., Carone S., Toma C., Van E.H., de J.M., Kemner C., Koop F., Langemeijer M., Hijmans C., Staal W.G., Baird G., Bolton P.F., Rutter M.L., Weisblatt E., Green J., Aldred C., Wilkinson J.A., Pickles A., Le C.A., Berney T., McConachie H., Bailey A.J., Francis K., Honeyman G., Hutchinson A., Parr J.R., Wallace S., Monaco A.P., Barnby G., Kobayashi K., Lamb J.A., Sousa I., Sykes N., Cook E.H., Guter S.J., Leventhal B.L., Salt J., Lord C., Corsello C., Hus V., Weeks D.E., Volkmar F., Tauber M., Fombonne E., Shih A., Meyer K.J. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 2007, 39:319-328.
230. Takahashi M., Seagar M.J., Jones J.F., Reber B.F., Catterall W.A. Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle. Proc. Natl. Acad. Sci. USA 1987, 84:5478-5482.
231. Takahashi T., Momiyama A. Different types of calcium channels mediate central synaptic transmission. Nature 1993, 366:156-158.
232. Tanabe T., Takeshima H., Mikami A., Flockerzi V., Takahashi H., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S. Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 1987, 328:313-318.
233. Templin C., Ghadri J.R., Rougier J.S., Baumer A., Kaplan V., Albesa M., Sticht H., Rauch A., Puleo C., Hu D., Barajas-Martinez H., Antzelevitch C., Luscher T.F., Abriel H., Duru F. Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). Eur. Heart J. 2011, 32:1077-1088.
234. Tesli M., Skatun K.C., Ousdal O.T., Brown A.A., Thoresen C., Agartz I., Melle I., Djurovic S., Jensen J., Andreassen O.A. CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PLoS ONE 2013, 8:e56970.
235. Ting J.T., Peca J., Feng G. Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. Annu. Rev. Neurosci. 2012, 35:49-71.
236. Tottene A., Conti R., Fabbro A., Vecchia D., Shapovalova M., Santello M., Van den Maagdenberg A.M., Ferrari M.D., Pietrobon D. Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice. Neuron 2009, 61:762-773.
237. Tottene A., Volsen S., Pietrobon D. alpha(1E) subunits form the pore of three cerebellar R-type calcium channels with different pharmacological and permeation properties. J. Neurosci. 2000, 20:171-178.
238. Triggle D.J. Calcium channel ligands. Ann. Rev. Pharmacol. Toxicol. 1987, 27:347-369.
239. Tringham E., Powell K.L., Cain S.M., Kuplast K., Mezeyova J., Weerapura M., Eduljee C., Jiang X., Smith P., Morrison J.L., Jones N.C., Braine E., Rind G., Fee-Maki M., Parker D., Pajouhesh H., Parmar M., O'Brien T.J., Snutch T.P. T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures. Sci. Transl. Med. 2012, 4. 121ra19.
240. Valdeolmillos M., O'Neill S.C., Smith G.L., Eisner D.A. Calcium-induced calcium release activates contraction in intact cardiac cells. Pflügers Arch. 1989, 413:676-678.
241. Walsh C.P., Davies A., Butcher A.J., Dolphin A.C., Kitmitto A. 3D structure of CaV3.1-comparison with the cardiac L-type voltage-gated calcium channel monomer architecture. J. Biol. Chem. 2009, 284:22310-22321.
242. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C., Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C., Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
243. Wang H., Sun H., Della P.K., Benz R.J., Xu J., Gerhold D.L., Holder D.J., Koblan K.S. Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases. Neuroscience 2002, 114:529-546.
244. Westenbroek R.E., Hell J.W., Warner C., Dubel S.J., Snutch T.P., Catterall W.A. Biochemical properties and subcellular distribution of an N-type calcium channel α1 subunit. Neuron 1992, 9:1099-1115.
245. 1A subunits of brain calcium channels. J. Neurosci. 1995, 15:6403-6418.
246. 2+ channels in supporting hippocampal synaptic transmission. Science 1994, 264:107-111.
247. Wheeler D.G., Groth R.D., Ma H., Barrett C.F., Owen S.F., Safa P., Tsien R.W. Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+) signaling to control CREB-dependent gene expression. Cell 2012, 149:1112-1124.
248. Williams M.E., Brust P.F., Feldman D.H., Patthi S., Simerson S., Maroufi A., McCue A.F., Veliçelebi G., Ellis S.B., Harpold M.M. Structure and functional expression of an w-conotoxin-sensitive human N-type calcium channel. Science 1992, 257:389-395.
249. Wilson S.M., Toth P.T., Oh S.B., Gillard S.E., Volsen S., Ren D., Philipson L.H., Fletcher C.F., Tessarollo L., Copeland N.G., Jenkins N.A., Miller R.J. The status of voltage-dependent calcium channels in α1E knockout mice. J. Neurosci. 2000, 20:8566-8571.
250. 2+ channel complex purified from brain. Science 1993, 261:486-489.
251. Wu L.G., Westenbroek R.E., Borst J.G.G., Catterall W.A., Sakmann B. Calcium channel types with distinct presynaptic localization couple differentially to transmitter release in single calyx-type synapses. J. Neurosci. 1999, 19:726-736.
252. Xiao H.S., Huang Q.H., Zhang F.X., Bao L., Lu Y.J., Guo C., Yang L., Huang W.J., Fu G., Xu S.H., Cheng X.P., Yan Q., Zhu Z.D., Zhang X., Chen Z., Han Z.G., Zhang X. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc. Natl. Acad. Sci. USA 2002, 99:8360-8365.
253. 2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J. Neurophysiol. 1997, 77:1003-1015.
254. Yatsenko S.A., Hixson P., Roney E.K., Scott D.A., Schaaf C.P., Ng Y.T., Palmer R., Fisher R.B., Patel A., Cheung S.W., Lupski J.R. Human subtelomeric copy number gains suggest a DNA replication mechanism for formation: beyond breakage-fusion-bridge for telomere stabilization. Hum. Genet. 2012, 131:1895-1910.
255. Yoshimizu T., Pan J.Q., Mungenast A.E., Madison J.M., Su S., Ketterman J., Ongur D., McPhie D., Cohen B., Perlis R., Tsai L.H. Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons. Mol. Psychiatry 2015, 20:162-169.
256. Yuen R.K., Thiruvahindrapuram B., Merico D., Walker S., Tammimies K., Hoang N., Chrysler C., Nalpathamkalam T., Pellecchia G., Liu Y., Gazzellone M.J., D'Abate L., Deneault E., Howe J.L., Liu R.S., Thompson A., Zarrei M., Uddin M., Marshall C.R., Ring R.H., Zwaigenbaum L., Ray P.N., Weksberg R., Carter M.T., Fernandez B.A., Roberts W., Szatmari P., Scherer S.W. Whole-genome sequencing of quartet families with autism spectrum disorder. Nat. Med. 2015, 21:185-191.
257. Zamponi G.W., Striessnig J., Koschak A., Dolphin A.C. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol. Rev. 2015, 67:821-870.
258. Zhang H., Maximov A., Fu Y., Xu F., Tang T.S., Tkatch T., Surmeier D.J., Bezprozvanny I. Association of CaV1.3 L-type calcium channels with Shank. J. Neurosci. 2005, 25:1037-1049.
259. 2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology 1993, 32:1075-1088.
260. Zhang Q., Shen Q., Xu Z., Chen M., Cheng L., Zhai J., Gu H., Bao X., Chen X., Wang K., Deng X., Ji F., Liu C., Li J., Dong Q., Chen C. The effects of CACNA1C gene polymorphism on spatial working memory in both healthy controls and patients with schizophrenia or bipolar disorder. Neuropsychopharmacology 2012, 37:677-684.